Search

Your search keyword '"Thackray, Larissa B."' showing total 240 results

Search Constraints

Start Over You searched for: Author "Thackray, Larissa B." Remove constraint Author: "Thackray, Larissa B."
240 results on '"Thackray, Larissa B."'

Search Results

1. Computationally restoring the potency of a clinical antibody against Omicron

2. A compendium of multi-omics data illuminating host responses to lethal human virus infections

3. Defining the risk of SARS-CoV-2 variants on immune protection

4. Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans

5. Hypergraph Models of Biological Networks to Identify Genes Critical to Pathogenic Viral Response

6. Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

8. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

9. Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 in mice.

10. Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2

13. Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics

14. Hypergraph models of biological networks to identify genes critical to pathogenic viral response

15. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

17. Potently neutralizing and protective human antibodies against SARS-CoV-2

19. Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2

21. CD209L (L-SIGN) Is a Receptor for Severe Acute Respiratory Syndrome Coronavirus

22. Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants

23. Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

24. Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains

25. Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant

26. Host network-based discovery of critical regulators of innate immunity, virus growth, and pathogenesis in influenza virus infection

27. Kathryn V. Holmes: A Career of Contributions to the Coronavirus Field

28. Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice

29. Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice

30. Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

33. Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

34. Additional file 2 of Hypergraph models of biological networks to identify genes critical to pathogenic viral response

35. Hypergraph models of biological networks to identify genes critical to pathogenic viral response

36. Additional file 4 of Hypergraph models of biological networks to identify genes critical to pathogenic viral response

37. Additional file 3 of Hypergraph models of biological networks to identify genes critical to pathogenic viral response

38. Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species

39. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

40. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

41. Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axis

43. Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection

44. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

45. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

46. The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis

47. Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

48. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

49. A commensal Clostridium species restricts systemic alphavirus dissemination through a type I interferon signaling axis

50. Immune correlates of tuberculosis disease and risk translate across species

Catalog

Books, media, physical & digital resources